Results 51 to 60 of about 18,094 (184)

Targeting gut microbiota as a therapeutic approach for neurodegenerative diseases

Neuroprotection, Volume 3, Issue 2, Page 120-130, June 2025.
The abstract depicts the gut‐brain axis, illustrating the bidirectional communication between the gastrointestinal tract and the central nervous system. Probiotics can induce the production of neurotrophins, neurotransmitters, SCFAs, and contribute to increased antioxidant levels, which can benefit brain health. In contrast, antibiotics can disrupt the
Tobiloba S. Olajide, Omamuyovwi M. Ijomone   +1 more
wiley   +1 more source

Pseudomembranous Colitis

, 2017
INTRODUCTION: Pseudomembranous colitis, also known as a Clostridium difficile colitis is a potentially life-threatening acute infectious colitis.  This colitis results from the effects of toxins produced by the overgrowth of Clostridium difficile ...
Zlatareva, DK, Nedevska, M, Georgieva, SV   +2 more
core   +1 more source

Pseudomembranous Colitis: Not Always Caused by Clostridium difficile [PDF]

, 2014
Although classically pseudomembranous colitis is caused by Clostridium difficile, it can result from several etiologies. Certain medications, chemical injury, collagenous colitis, inflammatory bowel disease, ischemia, and other infectious pathogens can ...
Hannah De Groot, Derek M. Tang, Guofeng Xie, Erik C. von Rosenvinge, Leyla J. Ghazi, Nathalie H. Urrunaga   +5 more
core   +1 more source

Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases

Advanced Science, Volume 12, Issue 13, April 3, 2025.
This article reviews the use of fecal microbiota transplantation (FMT) to treat intestinal diseases like recurrent Clostridioides difficile infection (rCDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). It discusses FMT's efficacy, influencing factors such as donor selection, recipient characteristics, and treatment protocols ...
Shuna Hou, Jiachen Yu, Yongshuang Li, Duoyi Zhao, Zhiyu Zhang   +4 more
wiley   +1 more source

Pseudomembranous colitis on aytopsy materials of large multi-type hospital [PDF]

, 2014
As a result of wide and irrational antibiotics using the problem of AAC has become an issue. According to medical sources Clostridium difficile-associated diarrhea (pseudomembranous colitis) is not registered and its clinical diagnostics is ...
V. V. Svistunov, V. A. Tsinzerling, E. I. Belinskaya   +2 more
core   +1 more source

Role of microbiota in pain: From bench to bedside

iMetaOmics, Volume 2, Issue 1, March 2025.
Pain is closely linked to microbes. The microbiota modulates pain perception through three mechanisms: microbiota‐derived metabolites, immunoregulation, and direct stimulation on neurons. Therapeutic strategies like probiotics, fecal microbiota transplantation, and dietary changes show significant potential in pain management.
Huiguang Ren, Bo Cao, Qixuan Xu, Ruiyang Zhao, Hanghang Li, Bo Wei   +5 more
wiley   +1 more source

Roentgenographs Features in Antibiotic-Associated Pseudomembranous Colitis [PDF]

, 1976
Four patients with pseudomembranous colitis, related to antibiotic therapy, had a wide spectrum of radiographic features. These ranged from mild, focal areas of mucosal irregularity to widespread involvement of the colon.
Cho, Kyung J., Ting, Y. M., Lee, Inkyu, Chuang, Vincent P.   +3 more
core   +1 more source

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis

Alimentary Pharmacology &Therapeutics, Volume 61, Issue 5, Page 835-851, March 2025.
The safety of vonoprazan was evaluated in an integrated analysis of data from clinical trials and post‐marketing experience in adults with symptomatic gastro‐oesophageal reflux disease or erosive oesophagitis. Vonoprazan was well tolerated, with a similar safety profile to proton pump inhibitor comparators.
Colin W. Howden, Philip Katz, Kenneth R. DeVault, David C. Metz, David Tamene, Neila Smith, Barbara Hunt, Yu‐Ming Chang, Stuart J. Spechler   +8 more
wiley   +1 more source

Harnessing the gut microbiome to enhance cancer immunotherapy: Current advances and future directions in microbiota‐based therapeutic strategies

MedComm – Future Medicine, Volume 3, Issue 4, December 2024.
Multiple roles of gut microbiota in tumor immunotherapy. Gut microbiota plays a crucial role in programming innate and acquired immune responses, often affecting immunotherapy efficacy. They serve as biomarkers of efficacy and prognosis, and provide insights into microbiota‐based therapeutic strategies.
Binyan Zhao, Bailing Zhou, Qing Li, Chunyan Su, Jing Ma, Li Yang   +5 more
wiley   +1 more source

Microbes as medicine

Annals of the New York Academy of Sciences, Volume 1541, Issue 1, Page 63-82, November 2024.
The explosion of research into the human microbiome has revealed the many ways in which our microbes enhance our health. Could these host‐associated microbes be exploited as novel therapies to treat disease? In this review, the various strategies for using microbes as medicine that have been thus far employed, as well as the potential new treatments of
Brendan A. Daisley, Emma Allen‐Vercoe
wiley   +1 more source